Maintained Sensitivity to EGFR Tyrosine Kinase Inhibitors in EGFR-Mutant Lung Cancer Recurring after Adjuvant Erlotinib or Gefitinib
Oxnard, G. R., Janjigian, Y. Y., Arcila, M. E., Sima, C. S., Kass, S. L., Riely, G. J., Pao, W., Kris, M. G., Ladanyi, M., Azzoli, C. G., Miller, V. A.Volume:
17
Language:
english
Journal:
Clinical Cancer Research
DOI:
10.1158/1078-0432.CCR-11-1080
Date:
October, 2011
File:
PDF, 246 KB
english, 2011